#reagent of france
Explore tagged Tumblr posts
royalty-nobility · 2 months ago
Text
Tumblr media
Phillip II, Duke of Orléans, Reagent of France
Artist: Nicolas de Largillierre (French, 1656-1746)
Date: Last quarter of the XVII century
Medium: Oil on Canvas
Collection: Museo del Prado, Madrid, Spain
Phillip II, Reagent of France
Depicted when he was about seven years old, with Roman half-armor and a red robe, Philip II of Orléans (Saint Cloud, August 2, 1674 - Versailles, December 2, 1723) rests his left hand on a scepter bearing a fleur-de-lis. Born to Philip I of Orleáns) and Élisabeth Charlotte of the Palatinate, Duchess of Bavaria. He was he grandson of Louis XIII and Ana of Austria, on his father´s side; and of the Palatinate Elector, Karl I Ludwig and Landgrave Charlotte of Hesse-Kassel, on his mother´s. He was Duke of Orléans and Reagent of France (1715-1723) until Louis XV came of age. He was also the father-in-law of Louis I of Spain.
2 notes · View notes
pantry-rats · 8 days ago
Text
Franco and Tinker actually interacted with each other as children at some point back in the day. Tink is 28, older than Franco. Tink's family moved from France temporarily to escape the war, they stay in Louisiana.
They always had a fixation for cards, but before playing poker, loved building houses of cards and setting up dominoes. So, Tinker was a kid minding their own business around the block and trying to build things. A little asshole like Franco who was already hostile at 12 and having issues at home probably got into a few afternoon scuffles.
I can see Franco destroying hours worth of domino set ups or card builds. Maybe stealing toys and trinkets as well like the brat he is. Foolishly creating an enemy instead of a friend. The family moves away eventually, and if i can imagine the timeline correctly, they dont see each other again from the time they are about early teenagers until meeting up at Sinyala.
Now, Franco forces Tink to sit strapped to traps and deadly life threatening contraptions while they play shitty rigged card games. (think RE7 lucas) Franco cheats every time because he is always losing every time. Tinker is naturally gifted with luck, which is why they're reagent 777. Also Franco has no hold against the insults Tinker can throw at him.
Guards. Roast him in french.
13 notes · View notes
fantasybooktournament · 2 years ago
Text
Mystery Fantasy Book Tournament
Round 1: Poll 5
The One with the Moving Castle
A princess' brother and parents go missing, presumed dead. People come to her castle from all around to help secure the next heir and reagent. But the castle can move, add and take away rooms and it's up to the princess to use these hints to figure out who ambushed her parents and brother and if they're still alive.
The One with Possessed Nuns
A young nun in fantasy-France lets a powerful revenant take possession of her body in order to protect her monastery from possessed soldiers. No one believes she can possibly control the evil creature, but as she uncovers a sinister plot at the very heart of her country, she finds herself growing closer to the revenant by the day.
107 notes · View notes
rottingchapel · 13 days ago
Text
Tumblr media Tumblr media
Two trials ocs.... left is Aveline right is Grease,, miss Aveline works for Murkoff as a scientist/surgeon and Grease is a reagent who is really, really tired
Blurb about Aveline below she's nefarious
Aveline was blackmailed by Murkoff because of an incident that happened while she was in med school in France, where an ex-classmate had dropped out and then been found in a cabin out in the farmlands. He'd been tortured to death. It wasn't pretty at all, especially because she'd been found tied to a fence post and nearly gutted. Her "boyfriend" at the time, a guy named Joseph, had a long history of violence and was found nearly overdosed on drugs.
Joseph swore up and down it'd all been her idea -- she told him her classmate had been stalking her and she just wanted Joseph to scare him, but she'd done most of the torture in the end, and he'd fallen asleep the night before and woke up to her stabbed in the gut and five cops standing over him. Aveline maintained her innocence: she had been told that Joseph had rented out the cabin for a weekend vacation, only for him to attack her when they arrived. Between a pretty young woman from a good family and a felon with a history of assault and drug use, it was easy for the public to decide who was telling the truth.
He was covered in blood at the scene of the crime, and Aveline's friends from school had all testified she'd told them he'd been getting violent with her lately, so he was easy to pin the charges to. Aveline survived with only a nasty scar on her abdomen to show she was even involved. Heralded as a survivor of a terrible attack, she graduated at the top of her class.
Murkoff knows she's the one who killed that med student, though, and she ends up in Sinyala as a surgeon/scientist for therapeutic salvage and expop maintenance.
9 notes · View notes
kaitropoli · 11 months ago
Text
Tumblr media
"Louise-Marie de Bourbon, dite Mademoiselle de Tours; La fillette aux bulles de savon"
By Pierre Mignard
Oil Painting, 1681.
Château de Versailles.
Tumblr media Tumblr media Tumblr media
PORTRAIT SUBJECT
La fillette aux bulles de savon, or the commonly found English title, Girl Blowing Soap Bubbles, is a portrait of innocence during the Franco-Dutch War.
The child shown is Louise-Marie de Bourbon, the daughter of the Sun King, Louis XIV, and his Maîtresse-en-titre, Françoise-Athénaïs de Rochechouart (Madame de Montespan). I'm sorry, I don't know why they popped off with the names like that when they're planning to reuse Marie and Louis fifty times over ptdr. Louise-Marie, affectionately known as Toutou, was an illegitimate birth (1674), later legitimized by her father when she was around two years old. She held the title of Mademoiselle de Tours from then until her untimely death in 1681.
According to sources, Mignard's painting of the six-year-old girl was finished posthumously. But, her innocence is held delicately, frozen in time on canvas.
Tumblr media
THEMES OF CHILDHOOD INNOCENCE (TL;DR: YAPANESE)
Mignard's choice to paint Louise-Marie as an actual child was uncommon for the time (even centuries later, believe it or not; maybe not so good examples, but for argument-sake: Louis XV by Hyacinthe Rigaud, Mariana Victoria of Spain by Nicolas de Largillierre, Phillip II, Duke of Orléans, Reagent of France by Largillierre, and Élisabeth Charlotte d'Orléans, "Mademoiselle de Chartres" by Largillierre -- apologies for throwing you strays, man, I'm trying to finish writing this and your children portraits were on the same website next to each other x), as young royalty are painted either as babies (unbreeched/baptize gown) or as tiny adults (fixed in uncomfortable poses and wearing clothes a monarch would), no in between. Here, Louise-Marie is playing with bubbles, her dog jumping towards it, and she looks carefree, still with chubby cheeks of rose. It doesn't help much that children were seen as heirs to the family fortune, especially during a time when parents had multiple kids due to illness (premature death) and bringing in income (need I explain more... *cough cough* coal mines... a bit anachronistic, sorry breaker boys, some other time we'll discuss y'all).
A painting such as this one, showing a realistic human experience from a royal status and that of a child BEING a child, innocence still intact, is quite important, even in today's form. We take childhood for granted, and kids are forced to grow up despite having more rights now than before. It can be a portrait to remind us that innocence is vital (a lack of childhood is detrimental as the experience is needed in order to mature mentally and emotionally when entering the teen and adult stages of life), but also that we as humans weren't so different from back then (sure, you can claim we bathe more than they do despite your husband still not washing his ass, but my heavens, did the thought 'wait, they had bubbles back then' ever occur to you?).
Genuinely, I was going to pull a La Muse Verte (the post where I briefly explained the history of absinthe) and go into the history of bubbles... because you gotta admit, that'd be fun for the both of us. However, delving into the background and theme of this painting became more heartbreaking for me. The bubble idea isn't gone, but it'll be postponed as a full history lesson post (and, yes, Mignard's painting of the immortalized Toutou will be recycled).
Tumblr media
FURTHER READING (EXTRA SYMBOLISTIC DETAIL)
Plenty more symbolism is present, but I highly recommend you all check out L'Art en Tête's in-depth article on Mignard's beautiful portrait. I did regurgitate some of the author's points in this because I thought they were brilliant, and you can tell they have an art-history degree, so I'm begging you to go over there for more detail if interested!
Tumblr media
10 notes · View notes
trendingreportz · 2 months ago
Text
Acetic Acid Market - Forecast(2024 - 2030)
Acetic Acid Market Overview
Acetic Acid Market Size is forecast to reach $14978.6 Million by 2030, at a CAGR of 6.50% during forecast period 2024-2030. Acetic acid, also known as ethanoic acid, is a colorless organic liquid with a pungent odor. The functional group of acetic acid is methyl and it is the second simplest carboxylic acid. It is utilized as a chemical reagent in the production of many chemical compounds. The major use of acetic acid is in the manufacturing of vinyl acetate monomer, acetic anhydride, easter and vinegar. It is a significant industrial chemical and chemical reagent used in the production of photographic film, fabrics and synthetic fibers. According to the Ministry of Industry and Information Technology, from January to September 2021, the combined operating revenue of 12,557 major Chinese garment companies was US$163.9 billion, showing a 9% increase. Thus, the growth of the textile industry is propelling the market growth for Acetic Acid.
Report Coverage
The “Acetic Acid Market Report – Forecast (2024-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Acetic Acid industry.
By Form: Liquid and Solid.
By Grade: Food grade, Industrial grade, pharmaceutical grade and Others.
By Application: Vinyl Acetate Monomer, Purified Terephthalic Acid, Ethyl Acetate, Acetic Anhydride, Cellulose Acetate, Acetic Esters, Dyes, Vinegar, Photochemical and Others 
By End-use Industry: Textile, Medical and Pharmaceutical, Oil and Gas, Food and Beverages, Agriculture, Household Cleaning Products, Plastics, Paints & Coating and Others.
By Geography: North America (the USA, Canada and Mexico), Europe (the UK, Germany, France, Italy, Netherlands, Spain, Russia, Belgium and the Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia and New Zealand, Indonesia, Taiwan, Malaysia and the Rest of APAC), South America (Brazil, Argentina, Colombia, Chile and the Rest of South America) and the Rest of the World (the Middle East and Africa).
Request Sample
Key Takeaways
The notable use of Acetic Acid in the food and beverages segment is expected to provide a significant growth opportunity to increase the Acetic Acid Market size in the coming years. As per the US Food and Agriculture Organization, world meat production reached 337 million tonnes in 2019, up by 44% from 2000.
The notable demand for vinyl acetate monomer in a range of industries such as textile finishes, plastics, paints and adhesives is driving the growth of the Acetic Acid Market. 
Increase in demand for vinegar in the food industry is expected to provide substantial growth opportunities for the industry players in the near future in the Acetic Acid industry.
Acetic Acid Market Segment Analysis – by Application
The vinyl acetate monomer segment held a massive 44% share of the Acetic Acid Market share in 2021. Acetic acid is an important carboxylic acid and is utilized in the preparation of metal acetates and printing processes, industrially. For industrial purposes, acetic acid is manufactured by air oxidation of acetaldehyde with the oxidation of ethanol, butane and butene. Acetic acid is extensively used to produce vinyl acetate which is further used in formulating polyvinyl acetate. Polyvinyl acetate is employed in the manufacturing of plastics, paints, textile finishes and adhesives. Thus, several benefits associated with the use of vinyl acetate monomer is boosting the growth and is expected to account for a significant share of the Acetic Acid Market.
Inquiry Before Buying
Acetic Acid Market Segment Analysis – by End-use Industry
The food and beverages segment is expected to grow at the fastest CAGR of 7.5% during the forecast period in the Acetic Acid Market. Acetic Acid is also known as ethanoic acid and is most extensively used in the production of vinyl acetate monomer. Vinyl acetate is largely used in the production of cellulose acetate which is further used in several industrial usage such as textiles, photographic films, solvents for resins, paints and organic esters. PET bottles are manufactured using acetic acid and are further utilized as food containers and beverage bottles. In food processing plants, acetic acid is largely used as cleaning and disinfecting products. Acetic acid is extensively used in producing vinegar which is widely used as a food additive in condiments and the pickling of vegetables. According to National Restaurant Association, the foodservice industry is forecasted to reach US$898 billion by 2022. Thus, the advances in the food and beverages industry are boosting the growth of the Acetic Acid Market. 
Acetic Acid Market Segment Analysis – by Geography
Asia-Pacific held a massive 41% share of the Acetic Acid Market in 2021. This growth is mainly attributed to the presence of numerous end-use industries such as textile, food and beverages, agriculture, household cleaning products, plastics and paints & coatings. Growth in urbanization and an increase in disposable income in this region have further boosted the industrial growth in this region. Acetic acid is extensively used in the production of metal acetates, vinyl acetate and vinegar which are further utilized in several end-use industries. Also, Asia-Pacific is one of the major regions in the domain of plastic production which provides substantial growth opportunities for the companies in the region. According to Plastic Europe, China accounted for 32% of the world's plastic production. Thus, the significant growth in several end-use industries in this region is also boosting the growth of the Acetic Acid Market.
Acetic Acid Market Drivers 
Growth in the textile industry:
Acetic Acid, also known as ethanoic acid, is widely used in the production of metal acetate and vinyl acetate which are further used in the production of chemical reagents in textiles, photographic films, paints and volatile organic esters. In the textile industry, acetic acid is widely used in textile printing and dyes. According to China’s Ministry of Industry and Information Technology, in 2020, textile and garment exports from China increased by 9.6% to US$291.22 billion. Also, according to the U.S. Department of Commerce, from January to September 2021, apparel exports increased by 28.94% to US$4.385 billion, while textile mill products rose by 17.31% to US$12.365 billion. Vinyl acetate monomer is utilized in the textile industry to produce synthetic fibers. Thus, the global growth in demand for textiles is propelling the growth and is expected to account for a significant share of the Acetic Acid Market size.
Schedule a call
Surge in use of vinegar in the food industry:
The rapid surge in population along with the adoption of a healthy and sustainable diet has resulted in an increase in demand for food items, thereby increasing the global production level of food items. As per US Food and Agriculture Organization, in 2019, global fruit production went up to 883 million tonnes, showing an increase of 54% from 2000, while global vegetable production was 1128 million tonnes, showing an increase of 65%. Furthermore, world meat production reached 337 million tonnes in 2019, showing an increase of 44% from 2000. Acetic acid is majorly used in the preparation of vinegar which is further widely utilized as a food ingredient and in personal care products. Vinegar is used in pickling liquids, marinades and salad dressings. It also helps to reduce salmonella contamination in meat and poultry products. Furthermore, acetic acid and its sodium salts are used as a food preservative. Thus, the surge in the use of vinegar in the food industry is boosting the growth of the Acetic Acid Market.
Acetic Acid Market Challenge
Adverse impact of acetic acid on human health:
Acetic Acid is considered a strong irritant to the eye, skin and mucous membrane. Prolong exposure to and inhalation of acetic acid may cause irritation to the nose, eyes and throat and can also damage the lungs. The workers who are exposed to acetic acid for more than two or three years have witnessed upper respiratory tract irritation, conjunctival irritation and hyperkeratotic dermatitis. The Occupational Safety and Health Administration (OSHA) reveals that the standard exposure to airborne acetic acid is eight hours. Furthermore, a common product of acetic acid i.e., vinegar can cause gastrointestinal tract inflammatory conditions such as indigestion on excess consumption. Thus, the adverse impact of Acetic Acid may hamper the market growth. 
Buy Now
Acetic Acid Industry Outlook
The top 10 companies in the Acetic Acid Market are:
Celanese Corporation
Eastman Chemical Company
LyondellBasell
British Petroleum
Helm AG
Pentoky Organy
Dow Chemicals
Indian Oil Corporation
Daicel Corporation
Jiangsu Sopo (Group) Co. Ltd.
Recent Developments
In March 2021, Celanese Corporation announced the investment to expand the production facility of vinyl portfolio for the company’s acetyl chain and derivatives in Europe and Asia.
In April 2020, Celanese Corporation delayed the construction of its new acetic acid plant and expansion of its methanol production by 18 months at the Clear Lake site in Texas.
In October 2019, BP and Chian’s Zhejiang Petroleum and Chemical Corporation signed MOU in order to create a joint venture to build a 1 million tonne per annum Acetic Acid plant in eastern China.
Key Market Players:
The Top 5 companies in the Acetic Acid Market are:
Celanese Corporation
Ineos Group Limited
Eastman Chemical Company
LyondellBasell Industries N.V.
Helm AG
For more Chemicals and Materials Market reports, please click here
2 notes · View notes
global-research-report · 19 days ago
Text
Europe Animal Health Market Analysis: Growth Drivers and Emerging Innovations
The Europe animal health market size was estimated at USD 16.5 billion in 2023 and it is projected to grow at a CAGR of 8.0% from 2024 to 2030. An increase in the number of pet owners, growing pet humanization, unceasing demand for meat and milk leading to a rise in livestock population, increase in the expenditure on veterinary medicines and other animal health products, growing awareness about animal welfare, government initiatives directed toward the wellbeing of animals, and growing availability of animal health solutions have driven the market growth in Europe.
Europe’s animal health market accounted for a 26.5% share (second-largest) of the global animal health industry in 2023. In recent years, the total population of production and companion animals has been on the rise. According to the FEDIAF 2023 report, 91 million households in the European Union region own a pet (46%), with around 127 million cats, 104 million dogs, and other pets. This population develops a huge demand for all sorts of animal health products including biologics, pharmaceuticals, diagnostics, equipment & disposables, medicinal feed activities, and other health-related solutions.
Europe Animal Health Market Segmentation
Pharmaceuticals led the market with the largest revenue share of 43.8% in 2023. Offerings such as parasiticides, anti-infective products, anti-inflammatory products, and analgesics are some of the pharmaceutical products used for animal health.
The production animals segment dominated the market with the largest revenue share of 65.7% in 2023. The global livestock population has been growing unceasingly and Europe holds a large share of this number.
Based on end-use, veterinary hospitals & clinics led the market with the largest revenue share of 72.1% in 2023. The point-of-care testing/in-house testing segment is projected to grow at a CAGR of 12.4% from 2024 to 2030.
The Poland animal health market is expected to experience a CAGR of 10.6% from 2024 to 2030. This growth can be attributed to a variety of drivers such as high milk consumption and dairy farming in the country, enhancements in economic conditions, and growing inclination of researchers to conduct clinical trials for animal health products.
Europe Animal Health Market Report Segmentation
This report forecasts revenue growth at a regional and country level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the Europe animal health market report based on product, animal type, end-use, distribution channel and country.
Product Outlook (Revenue, USD Billion, 2018 - 2030)
Biologics
Vaccines
Modified/ Attenuated Live
Inactivated (Killed)
Other Vaccines
Other Biologics
Pharmaceuticals
Parasiticides
Anti-infectives
Anti-inflammatory
Analgesics
Others
Medicinal Feed Additives
Diagnostics
Consumables, reagents and kits
Instruments and devices
Equipment & Disposables
Critical Care Consumables
Anesthesia Equipment
Fluid Management Equipment
Temperature Management Equipment
Rescue & Resuscitation Equipment
Research Equipment
Patient Monitoring Equipment
Others
Veterinary Telehealth
Veterinary Software
Livestock Monitoring
Animal Type Outlook (Revenue, USD Billion, 2018 - 2030)
Production Animals
Poultry
Swine
Cattle
Sheep & Goats
Fish
Companion Animals
Dogs
Cats
Horses
Others
End-use Outlook (Revenue, USD Billion, 2018 - 2030)
Veterinary Reference Laboratories
Point-of-care Testing/In-house Testing
Veterinary Hospitals & Clinics
Others
Distribution Channel Outlook (Revenue, USD Billion, 2018 - 2030)
Retail
E-Commerce
Hospital/ Clinic Pharmacy
Country Outlook (Revenue, USD Billion, 2018 - 2030)
Germany
France
Italy
Spain
Switzerland
Netherlands
Russia
Sweden
UK
Poland
Ireland
Order a free sample PDF of the Europe Animal Health Market Intelligence Study, published by Grand View Research.
0 notes
surbhijamdade · 2 months ago
Text
Revenue Forecast and Competitive Landscape for the Oligonucleotide Synthesis Market
Tumblr media
The Oligonucleotide Synthesis Market Report for 2024 provides a comprehensive overview of the Oligonucleotide Synthesis Market industry, presenting crucial data and insights into market dynamics, including growth drivers, challenges, and future potential. The report evaluates the Oligonucleotide Synthesis Market Components, focusing on significant opportunities and trends that could shape the industry's trajectory.
According to Straits Research, the global Oligonucleotide Synthesis Market market size was valued at USD 7.74 billion in 2023. It is projected to reach from USD 8.84 billion in 2024 to USD 25.57 billion by 2032, growing at a CAGR of 14.2% during the forecast period (2024–2032).
Get a Sample PDF/Excel of report starting from USD 995 :https://straitsresearch.com/report/oligonucleotide-synthesis-market/request-sample
Top Key Players of Oligonucleotide Synthesis Market :
Agilent Technologies, Inc.
ATDBio Ltd.
TriLink BioTechnologies LLC
Thermo Fisher Scientific
Nitto Denko Corporation
Merck KGaA
LGC Biosearch Technologies
Integrated DNA Technologies, Inc.
GenScript
GE Healthcare
Eurogentec
Eurofins
and more....
Key Insights from the Oligonucleotide Synthesis Market Report
Market Size Overview: The report provides comprehensive estimates of the Oligonucleotide Synthesis Marketsize, including value and sales volume, for the period.
Market Trends and Dynamics: An analysis of the key drivers, opportunities, challenges, and risks shaping the Oligonucleotide Synthesis Market.
Global Economic and Regional Impact: Evaluation of the effects of global inflation and the Russia-Ukraine conflict on the Oligonucleotide Synthesis Market.
Trade Flow Analysis: Detailed examination of import and export volumes of Oligonucleotide Synthesis Marketacross major regions.
Industry Value Chain: Insight into the Oligonucleotide Synthesis Marketvalue chain, covering raw materials, suppliers, manufacturing processes, distributors, and downstream customers.
Industry News, Policies, and Regulations: Coverage of the latest developments, policies, and regulations impacting the Oligonucleotide Synthesis Market.
Regional Analysis for Oligonucleotide Synthesis Market:
The regional analysis section of the report offers a thorough examination of the global Oligonucleotide Synthesis Market market, detailing the sales growth of various regional and country-level markets. It includes precise volume analysis by country and market size analysis by region for both past and future periods. The report provides an in-depth evaluation of the growth trends and other factors impacting the Oligonucleotide Synthesis Market market in key countries, such as the United States, Canada, Mexico, Germany, France, the United Kingdom, Russia, Italy, China, Japan, Korea, India, Southeast Asia, Australia, Brazil, and Saudi Arabia. Moreover, it explores the progress of significant regional markets, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.
Oligonucleotide Synthesis Market Segmentations:
By Product Type
Synthesized Oligonucleotide Product
Reagents
Equipment
By Applications
Research
PCR
Sequencing
Gene Synthesis
Diagnostics
Therapeutics
RNAi
Nucleic Acid Aptamers
Others
By End-User
Academic Research Institutes
Pharmaceutical and Biotechnology Companies
Diagnostic Laboratories
Others
Get Detail Market Segmentation :https://straitsresearch.com/report/oligonucleotide-synthesis-market/segmentation
Unit Economics must be known by C-suite professionals:
Cost of Goods Sold (COGS): Includes material, labor, and overhead costs in manufacturing.
R&D Costs: Investment in innovation and compliance with regulations.
Engineering and Design Costs: Resources for design, prototyping, and meeting technical standards.
Production Costs: Specialized manufacturing and quality control expenses.
Supply Chain Costs: Managing procurement and logistics for specialized components.
Testing and Quality Assurance: Costs for ensuring product safety and reliability.
SG&A Costs: Marketing, sales, and administrative expenses.
Revenue per Unit: Income from contracts, services, and licensing.
Gross Margin: Revenue minus COGS, showing unit profitability.
Break-even Analysis: Units or contracts needed to cover total costs.
Customer Acquisition Cost (CAC): Costs to secure new contracts.
Lifetime Value (LTV): Total revenue from a customer over time.
Capital Expenditure (CapEx): Investments in facilities and technology.
Economies of Scale: Cost reductions in larger production runs.
Profit Margin: Final profit after all expenses.
Top Reasons to Choose This Report
Access to Comprehensive Insights: Gain access to extensive analysis, research, and data that are often challenging to gather independently. This report provides valuable information, saving you significant time and effort.
Support for Informed Decisions: Enhance your decision-making process with in-depth insights into market trends, consumer behavior, and key industry factors. This report is essential for strategic planning, including investments, product development, and marketing strategies.
Gain a Competitive Edge: Stay competitive by understanding market dynamics and competitor strategies. The report provides detailed insights into competitor performance and market trends, helping you craft effective business strategies.
Cost-Effective Research Solution: Save on research costs by investing in this report, which offers a detailed and comprehensive analysis of the market. This cost-effective option eliminates the need for extensive independent research.
COVID-19 Aftermath and Geopolitical Influences: Russia-Ukraine Conflict and Middle East Crisis
The report explores the multifaceted impact of COVID-19 on the Oligonucleotide Synthesis Market market, covering both direct and indirect effects across global and local levels. It discusses market size, trends, and growth trajectories in the Oligonucleotide Synthesis Market , classified by type, application, and customer sector. Additionally, it provides a detailed evaluation of market development components before and after the pandemic, supported by a PESTEL analysis to assess key influencers and barriers to market entry. We offer the flexibility to customize the report based on specific regions, applications, or any other statistical details. Our goal is to align our analysis with your specific needs, ensuring a more complete market study. The final report will also examine the impact of the Russia-Ukraine War on the Oligonucleotide Synthesis Market market, assessing how these geopolitical events are influencing current market conditions and future opportunities.
This Report is available for purchase on :https://straitsresearch.com/buy-now/oligonucleotide-synthesis-market
About Us:
Straits Research is a leading research and intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & research reports.
Contact Us: email: [email protected] Address: 825 3rd Avenue, New York, NY, USA, 10022 Tel: +1 646 905 0080 (U.S.) +91 8087085354 (India) +44 203 695 0070 (U.K.)
0 notes
teachingwithsnd · 2 months ago
Text
0 notes
trendingrepots · 2 months ago
Text
Molecular Diagnostics Market - Forecast, 2024 - 2030
Molecular Diagnostics Market Overview
The Molecular Diagnostics Market Size is forecast to reach $ 3240.4 Million by 2030, at a CAGR of 8.60% during forecast period 2024-2030. Molecular diagnostics can be demarcated as a group of techniques proficient in identifying specific genetic disparities in patients by using diverse technologies such as polymerase chain reaction, single nucleotide polymorphisms, electrophoresis, isothermal nucleic acid amplification technology, mass spectrometry to scrutinize biomarkers in the genome. Molecular diagnostics allows doctors to select an unsurpassed form of therapy by supporting the detection of maladies and possible risks. Moreover, it helps medical professionals to chart individualized or customer-specific plans. Therefore, accurate prescription and treatment duration help patients circumvent lengthy recapitulations of pointless drugs being used on patients recurrently with hostile effects. Besides cancer monitoring, molecular diagnostic can be used to manage infections like methicillin-resistant staphylococcus. Nevertheless, rising incidences of infections and cancer, augmenting health attentiveness among people, hiking demand for personalized medicines, and enlarging research and developmental activities are the factors set to drive the growth of the Molecular Diagnostics Industry for the period 2024-2030.
 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐑𝐞𝐩𝐨𝐫𝐭 𝐒𝐚𝐦𝐩𝐥𝐞
Report Coverage
The report: “Molecular Diagnostics Market Forecast (2024-2030)” by Industry ARC covers an in-depth analysis of the following segments of the Molecular Diagnostics Market.
By Product: Reagents, Instrument, and other devices.
By Application: Leukocyte Antigen Typing, Oncology, Blood screening, Transferrable ailments, and Others.
By Technology: TMA, In Situ Hybridization, PCR, DNA sequencing, INAAT, and Others.
By End User: Hospitals, Laboratories, CROs, and Other medical facilities.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and Rest of World (the Middle East and Africa).
Tumblr media
Key Takeaways
Geographically, North America’s Molecular Diagnostics Market accounted for the highest revenue share in 2021. The growth is owing to full-fledged healthcare infrastructure, the presence of top-notch pharmacy and biopharmaceutical companies, and the high disposable income of people. Furthermore, Asia-Pacific is poised to offer lucrative growth opportunities over the forecast period owing to rising disposable incomes and the higher class of the geriatric population, among many other reasons.
Intensifying cancer cases are said to be the preeminent driver driving the growth of the Molecular Diagnostics Market. The exorbitant cost of the associated treatments and instruments is said to reduce the market growth.
Detailed analysis on the Strength, Weaknesses, and Opportunities of the prominent players operating in the market will be provided in the Molecular Diagnostics Market report.
0 notes
harshnews · 3 months ago
Text
Professional Diagnostics Market Size, Share, Trends, Growth and Competitive Analysis
"Professional Diagnostics Market – Industry Trends and Forecast to 2029
Global Professional Diagnostics Market, By Product Type (Immunochemistry, Clinical Microbiology, Point Of Care Test (POCT), Haematology And Haemostasis) , End Users (Hospital, Diagnostic Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.
Access Full 350 Pages PDF Report @
The professional diagnostics market is a critical segment of the healthcare industry that plays a fundamental role in diagnosing diseases and medical conditions accurately and efficiently. This market is driven by factors such as the increasing prevalence of chronic diseases, technological advancements in diagnostic devices, growing awareness about early disease detection, and the expanding geriatric population. The global professional diagnostics market is expected to experience significant growth in the coming years due to these factors. The market can be analyzed on the basis of product type, application, and end-users.
**Segments**
- **Product Type**: - Reagents & Kits - Instruments - Data Management Software - Services
- **Application**: - Infectious Diseases - Oncology - Cardiology - Pharmacogenomics - Others
- **End-Users**: - Hospitals - Clinics - Diagnostic Laboratories - Research Institutes
The professional diagnostics market is highly competitive and is characterized by the presence of several key players that offer a wide range of diagnostic products and services. These market players focus on strategic initiatives such as mergers and acquisitions, partnerships, and product innovations to maintain their market position and gain a competitive edge.
**Market Players**
- Roche Diagnostics - Siemens Healthineers - Abbott Laboratories - Danaher Corporation - Thermo Fisher Scientific - Sysmex Corporation - Bio-Rad Laboratories - BioMérieux - Qiagen - Hologic
These market players invest heavily in research and development activities to introduce innovative diagnostic solutions that cater to the evolving healthcare needs of patients and healthcare providers. They also emphasize expanding their global presence through collaborations and partnerships with regional players to enhance their market reach and customer base.
In conclusion, the professional diagnostics market is poised for robust growth due to the increasing demand for accurate and rapid diagnostic solutions. The market is driven by technological advancements, rising healthcare expenditure, and the growing awareness about preventive healthcare measures.The professional diagnostics market is a crucial component of the healthcare industry, with a focus on accurate and efficient disease diagnosis. One of the key drivers propelling the growth of this market is the increasing prevalence of chronic diseases globally. Chronic conditions such as diabetes, cardiovascular diseases, and cancer require timely and precise diagnosis for effective treatment and management. Additionally, the aging population contributes to the demand for diagnostic services, as the elderly are more susceptible to various health issues that necessitate regular monitoring and diagnosis.
Technological advancements in diagnostic devices have revolutionized the way diseases are detected and diagnosed. Innovations such as point-of-care testing, molecular diagnostics, and advanced imaging techniques have significantly improved the accuracy and speed of diagnosis, leading to better patient outcomes. These technological advancements have also paved the way for personalized medicine and precision healthcare, where treatments are tailored to individual patients based on their genetic makeup and specific disease characteristics.
Another driving factor in the professional diagnostics market is the increasing awareness about the importance of early disease detection. Routine screening and diagnostic tests help in the early identification of diseases, enabling prompt intervention and treatment, which can lead to better prognosis and improved quality of life for patients. Governments and healthcare organizations worldwide are investing in awareness campaigns and screening programs to encourage regular health check-ups and early diagnosis, thereby driving the demand for diagnostic services and products.
The professional diagnostics market can be segmented based on product type, application, and end-users, offering a comprehensive view of the diverse offerings in this industry. Reagents & kits, instruments, data management software, and services constitute the product types available in the market, catering to different diagnostic needs and preferences. Applications such as infectious diseases, oncology, cardiology, and pharmacogenomics highlight the wide range of conditions that can be diagnosed using professional diagnostic services. Furthermore, end-users such as hospitals, clinics, diagnostic laboratories, and research institutes represent the diverse settings where diagnostic tests are performed, showcasing the broad reach and impact of this market.
The competitive landscape of the professional diagnostics market is**Global Professional Diagnostics Market, By Product Type (Immunochemistry, Clinical Microbiology, Point Of Care Test (POCT), Haematology And Haemostasis) , End Users (Hospital, Diagnostic Centers, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.**
- The professional diagnostics market is witnessing significant growth and innovation in product types such as Immunochemistry, Clinical Microbiology, Point of Care Test (POCT), Haematology, and Haemostasis. These advancements are crucial in providing accurate and timely diagnostic solutions for a wide range of diseases and medical conditions.
- The end-users of professional diagnostics products and services primarily include hospitals, diagnostic centers, and other healthcare facilities. The increasing demand for diagnostic tests in these settings is driving the growth of the market globally, with a focus on improving patient outcomes and healthcare delivery.
- Geographically, the professional diagnostics market spans across regions such as the U.S., Canada, Mexico, European countries like Germany, Italy, U.K., France, Spain, Netherlands
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on the product portfolios of the top players in the Professional Diagnostics Market.
Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the market.
Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments of the leading players in the market.
Market Development: Comprehensive information about emerging markets. This report analyzes the market for various segments across geographies.
Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Professional Diagnostics Market.
Global Professional Diagnostics Market survey report analyses the general market conditions such as product price, profit, capacity, production, supply, demand, and market growth rate which supports businesses on deciding upon several strategies. Furthermore, big sample sizes have been utilized for the data collection in this business report which suits the necessities of small, medium as well as large size of businesses. The report explains the moves of top market players and brands that range from developments, products launches, acquisitions, mergers, joint ventures, trending innovation and business policies.
The following are the regions covered in this report.
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
The Middle East & Africa [GCC, North Africa, South Africa, Rest of the Middle East and Africa]
This study answers to the below key questions:
What are the key factors driving the Professional Diagnostics Market?
What are the challenges to market growth?
Who are the key players in the Professional Diagnostics Market?
What are the market opportunities and threats faced by the key players?
Browse Trending Reports:
Threat Detection Systems Market Pipe Coating Market Fragrance Fixatives Market Mobile Campaign Management Platform Market Menstrual Cramps Treatment Market Roof Insulation Market Mobile Robotics Market Varnish Makers Market Urinary Incontinence Market Treatment Resistant Depression Market Robotic Prosthetics Market Neutropenia Market Polycystic Kidney Disease Adpkd Market Grain Analysis Market Solid State Solar Cell Market Panel Mount Industrial Display Market Automotive Mini Led Market
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
Tumblr media
0 notes
industrynewsupdates · 3 months ago
Text
Nurse Call Systems Market Key Companies, Growth and Forecast Report, 2030
The global nurse call systems market size was valued at USD 1.7 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 12.11% from 2023 to 2030. 
The growing need for a diverse and integrated platform that increases the preference for mobility aids are driving the market. Medicare decides to refund schemes based on quality and outcome rather than quantity owing to the rising healthcare cost. Medicare estimates that current reimbursement practices are costing an additional USD 2.1 billion and expects to curtail this by using technology-focused healthcare. With this change in reimbursement policies, hospitals and other healthcare facilities are trying to streamline their workflow processes by adopting technology-oriented nurse call systems.
Nurse call systems enable reliable and flexible communication between the patient and the caregiver. Increasing patient numbers in healthcare facilities and the introduction of advanced ways to expand communication, workflow, and management to provide quality patient care are fueling the market growth. The market is primarily driven by technological advancements that have allowed players to create innovative devices. For instance, in December 2019, Tunstall Group launched Tunstall Carecom, a wireless and digital nurse call system.
Gather more insights about the market drivers, restrains and growth of the Nurse Call Systems Market
Blood Screening Market Report Highlights
• The reagent segment accounted for the largest revenue share of around 73.0% in 2022 and is expected to grow at the fastest CAGR of 12.0% over the forecast period.
• North America dominated the market and accounted for the largest revenue share of 39.0% in 2022 owing to the presence of key industry players, increased adoption of the blood screening process, stringent FDA regulations for transfusion, rising infectious disease prevalence, and greater patient affordability are responsible for maintaining its position during the forecast period.
• Asia Pacific is expected to grow at the fastest CAGR of 13.5% over the forecast period owing to increasing awareness about blood donation, rising patient affordability, and the focus of key industry players on emerging countries in the region.
Browse through Grand View Research's Medical Devices Industry Research Reports.
• The global emergency medical services product market size was valued at USD 22.5 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2030.
• The global scanning electron microscopes market size was valued at USD 4.34 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 8.6% from 2024 to 2030. 
Blood Screening Market Segmentation
Grand View Research has segmented the blood screening market by product, technology, and region:
Blood Screening Technology Outlook (Revenue, USD Million, 2018 - 2030)
• Nucleic Acid Amplification Test (NAT)
• ELISA
• Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
• Next Generation Sequencing
• Western Blotting
Blood Screening Product Outlook (Revenue, USD Million, 2018 - 2030)
• Reagent
• Instrument
Blood Screening Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
o U.S.
o Canada
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Sweden
o Norway
o Denmark
• Asia Pacific
o Japan
o China
o India
o Australia
o Thailand
o South Korea
• Latin America
o Brazil
o Mexico
o Argentina
• Middle East and Africa
o Saudi Arabia
o South Africa
o UAE
o Kuwait
Order a free sample PDF of the Nurse Call Systems Market Intelligence Study, published by Grand View Research.
0 notes
shubhampawrainfinium · 4 months ago
Text
Unraveling Gene Mysteries: The Role of Transcriptomics Technologies
Tumblr media
Introduction
The transcriptomics technologies market is experiencing robust growth due to advancements in genomics, an increasing emphasis on personalized medicine, and the rising demand for comprehensive gene expression analysis. Transcriptomics, the study of RNA transcripts produced by the genome under specific circumstances, provides critical insights into gene expression and regulation, offering valuable information for various applications including disease research, drug development, and personalized medicine. This market research report aims to offer a detailed analysis of the transcriptomics technologies market, exploring key market dynamics, regional trends, market segmentation, competitive landscape, and future outlook.
Market Dynamics
Drivers
Advancements in Genomics: Rapid technological advancements in sequencing technologies, such as next-generation sequencing (NGS) and microarrays, are driving the growth of the transcriptomics technologies market. These technologies enable high-throughput gene expression analysis and detailed transcriptome mapping.
Increasing Demand for Personalized Medicine: There is a growing focus on personalized medicine, which requires comprehensive gene expression data to tailor treatments to individual patients. Transcriptomics technologies are essential for understanding gene expression profiles and developing targeted therapies.
Rising Research and Development Activities: Increasing investments in R&D activities by pharmaceutical and biotechnology companies to discover novel biomarkers and therapeutic targets are driving the demand for transcriptomics technologies.
Challenges
High Cost of Technologies: The high cost associated with advanced transcriptomics technologies, including sequencing platforms and associated reagents, can be a barrier to widespread adoption, particularly in resource-limited settings.
Data Management and Analysis: The vast amount of data generated from transcriptomics studies poses challenges in terms of data management, storage, and analysis. Handling and interpreting large-scale transcriptomic data require specialized tools and expertise.
Complexity of Transcriptome Analysis: The complexity of transcriptome data, including the presence of alternative splicing and post-transcriptional modifications, adds to the analytical challenges and can complicate data interpretation.
Opportunities
Technological Innovations: Continued advancements in transcriptomics technologies, such as improvements in sequencing accuracy and the development of novel analytical tools, present significant opportunities for market growth.
Expansion into Emerging Markets: Growing investments in healthcare and research infrastructure in emerging markets offer new opportunities for the adoption of transcriptomics technologies.
Integration with Other Omics Technologies: Integrating transcriptomics with other omics technologies (e.g., proteomics, metabolomics) can provide a more comprehensive understanding of biological systems, creating opportunities for innovative research and applications.
Sample Pages of  Report: https://www.infiniumglobalresearch.com/reports/sample-request/952
Regional Analysis
North America: North America holds a dominant position in the transcriptomics technologies market due to the presence of leading technology providers, well-established research institutions, and high healthcare expenditure. The United States and Canada are key contributors to market growth in this region.
Europe: Europe also represents a significant market for transcriptomics technologies, supported by strong research capabilities, government funding, and increasing focus on personalized medicine. Countries such as Germany, the UK, and France are leading contributors.
Asia-Pacific: The Asia-Pacific region is expected to experience rapid growth in the transcriptomics technologies market due to increasing research activities, expanding healthcare infrastructure, and rising investments in biotechnology. China and India are emerging as key players in this market.
Latin America: Latin America is gradually adopting transcriptomics technologies, with growth driven by increasing research initiatives and improvements in healthcare infrastructure. Brazil and Mexico are notable markets in this region.
Middle East & Africa: The Middle East & Africa region shows potential for growth, supported by increasing investments in healthcare and research. However, market development may be slower due to economic and infrastructure challenges.
Market Segmentation
The transcriptomics technologies market can be segmented based on technology, application, end-user, and region:
By Technology:
Next-Generation Sequencing (NGS)
Microarrays
Real-Time PCR
Others (e.g., RNA Sequencing, in situ hybridization)
By Application:
Biomarker Discovery
Drug Development
Disease Research
Personalized Medicine
Others (e.g., Agricultural Research, Environmental Studies)
By End-User:
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Hospitals and Diagnostic Laboratories
Others (e.g., Contract Research Organizations)
Competitive Landscape
Market Share of Large Players: Large players dominate the transcriptomics technologies market, holding significant shares due to their extensive product portfolios, strong R&D capabilities, and established market presence.
Price Control: Big players have substantial influence over market pricing, leveraging their economies of scale and advanced technologies. However, competitive pricing strategies from smaller companies also affect pricing dynamics.
Competition from Small and Mid-Size Companies: Small and mid-size companies challenge larger players by offering innovative technologies and specialized solutions. These companies often focus on niche markets and provide unique value propositions.
Key Players: Major players in the transcriptomics technologies market include Illumina, Inc., Thermo Fisher Scientific, Agilent Technologies, Roche Holding AG, and Qiagen N.V.
Report Overview: https://www.infiniumglobalresearch.com/reports/global-transcriptomics-technologies-market
Future Outlook
New Product Development: New product development plays a critical role in the transcriptomics technologies market. Innovations such as enhanced sequencing technologies and novel data analysis tools are expected to drive market growth and address existing challenges. Companies investing in R&D to develop cutting-edge products are likely to gain a competitive advantage.
Sustainable Products: There is a growing emphasis on sustainability in the life sciences industry. Sustainable practices and products, such as eco-friendly reagents and energy-efficient technologies, are gaining traction. Companies that focus on sustainability are likely to appeal to environmentally-conscious customers and enhance their market position.
Conclusion
The transcriptomics technologies market is on a growth trajectory, driven by technological advancements, increasing demand for personalized medicine, and expanding research activities. Despite challenges such as high costs and data complexity, the market presents significant opportunities for innovation and expansion. Companies that leverage technological advancements, focus on new product development, and adopt sustainable practices will be well-positioned to succeed in this evolving market. As the field of transcriptomics continues to advance, staying attuned to emerging trends and market demands will be crucial for achieving long-term success.
0 notes
tamanna31 · 4 months ago
Text
Blood Screening Market 2023- Business Planning Research and Resources, Revenue, and Forecasts 2030
Blood Screening Market Size & Trends
The global blood screening market size was valued at USD 2.76 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 11.7% from 2023 to 2030. 
Blood screening is a process in which donated blood is screened for infectious diseases such as HBV, HCV, HIV1, and HIV2. The high growth of this market is attributed to rising blood donations, an increase in the incidence of infectious diseases, and government initiatives. According to World Health Organization (WHO), 118.54 million blood donations are collected yearly. In the U.S., 6.8 million individuals donate blood annually, and 13.6 million units of red blood cells and whole blood are collected annually.
Gather more insights about the market drivers, restrains and growth of the Blood Screening Market
The market is primarily driven by the rise in the rate of disorders such as HIV, diphtheria, measles and chronic diseases such as hemophilia, cancer, and other blood-related disorders. Blood-based diagnostics are used to diagnose a wide range of diseases, including infectious diseases, cancer, and cardiovascular diseases. Serology tests detect the presence of antibodies to a specific disease-causing organism. These tests diagnose various infectious diseases, including HIV, hepatitis B, and syphilis. Molecular tests detect the presence of DNA or RNA from a specific disease-causing organism. These tests are more sensitive than serology tests and can be used to diagnose diseases at an earlier stage. Biochemical tests measure the levels of certain substances in the blood. These tests can diagnose a wide range of diseases, including diabetes, kidney disease, and liver disease.
The COVID-19 pandemic had a significant impact on the market. Although respiratory droplets are the primary means of COVID-19 virus transmission, research has shown that viral RNA may be discovered in blood samples, supporting blood screening for COVID-19 identification, hence driving the market significantly. 
Blood Screening Market Segmentation
Grand View Research has segmented the global blood screening market based on technology, product, and region:
Technology Outlook (Revenue, USD Million, 2018 - 2030)
Nucleic Acid Amplification Test (NAT)
ELISA
Chemiluminescence Immunoassay (CLIA) and Enzyme Immunoassay (EIA)
Next Generation Sequencing
Western Blotting
Product Outlook (Revenue, USD Million, 2018 - 2030)
Reagent
Instrument
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
US
Canada
Europe
UK
Germany
France
Italy
Spain
Sweden
Norway
Denmark
Asia Pacific
Japan
China
India
Australia
Thailand
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East and Africa
Saudi Arabia
South Africa
UAE
Kuwait
Browse through Grand View Research's Medical Devices Industry Research Reports.
The global embolic protection devices market size was valued at USD 612.9 million in 2023 and is projected to grow at a CAGR of 8.7% from 2024 to 2030. 
The global covered stent market size was estimated at USD 1.13 billion in 2023 and is projected to grow at a CAGR of 4.1% from 2024 to 2030. 
Key Companies & Market Share Insights
Product launches, approvals, strategic acquisitions, and innovations are just a few of the important business strategies used by market participants to maintain and grow their global reach.
For instance, in March 2023, Abbott received U.S Food and Drug Administration (FDA) clearance for a laboratory traumatic brain injury blood test, the first commercially available lab-based test for the assessment of mild traumatic brain injuries (TBIs), commonly referred to as concussions, which will be made widely available to hospitals across the U.S. This test, which is powered by Abbott’s Alinity i laboratory tool, will enable clinicians to evaluate individuals with mild traumatic brain injuries in a timely manner.
Furthermore, in May 2023, Siemens Healthcare introduced Atellica HEMA 570 and 580 next-generation hematology analyzers, which have user-friendly interfaces and can be connected to multiple analyzers to remove workflow barriers and provide high throughput time.
Key Blood Screening Companies:
Abbott
Danaher Corporation (Beckman Coulter)
Becton Dickinson and Company
Bio-Rad Laboratories, Inc.
Hoffman-La Roche Ltd.
Grifols, S.A.
Ortho-Clinical Diagnostics, Inc.
Siemens Healthcare GmbH
Thermo Fisher Scientific, Inc.
SOFINA s.a (Biomerieux)
Order a free sample PDF of the Blood Screening Market Intelligence Study, published by Grand View Research. 
0 notes
communicationblogs · 4 months ago
Text
Digital PCR Market — Forecast(2024–2030)
Digital PCR Market Overview
Tumblr media
Request Sample
Report Coverage
The report: “Digital PCR Market Forecast (2024–2030)”, by Industry ARC, covers an in-depth analysis of the following segments of the Digital PCR Market.
By Product: Consumables & Reagents and Software & Services
By Technology Type: Droplet Digital PCR, Chip Based Digital PCR, and Beaming Digital PCR
By Indication: Infectious Disease, Oncology, Genetic Disorders, and Others
By Application: Research, Clinical Diagnostics, Forensics, and Others
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (Middle East, and Africa).
Inquiry Before Buying
Key Takeaways
North America dominated the Digital PCR Market in 2020 owing to the increasing demand for rapid diagnostic tests and high diagnosis rates for infectious disease. The Digital PCR Market scope for different regions will be provided in the final report.
Technological advancements in digital PCR and growing adoption of digital PCR over real time PCR are likely to aid the market growth of the Digital PCR Market report.
Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Digital PCR Market report.
High cost of digital PCR devices and reimbursement issues along with the technical limitations of PCR is poised to create hurdles for the Digital PCR Market.
Digital PCR Market Segment Analysis — By Technology Type
Droplet Digital PCR held the largest share in the Digital PCR Market in 2020 and is estimated to grow at a CAGR of 9.7% during the forecast period 2024–2030. This is attributed to the technological advances along with various new product launches. Droplet digital PCR is based on water oil emulsion droplet technology and for the amplification of the template molecules in each individual droplet. It also uses workflows and reagents for most standard probe based assays. Droplet digital PCR also measure the copy number variation by partitioning a PCR reaction into nanoliter droplets. The cross-contamination drawback of droplet digital PCR is increasing the demand of chip based digital PCR. Droplet digital PCR are estimated to register the highest CAGR over the period 2024–2030.
Schedule a Call
Digital PCR Market Segment Analysis — By Indication
Infectious disease held the largest share in the Digital PCR Market in 2020 and is estimated to grow at a CAGR 8.6% during the forecast period 2021–2026. This is attributed to the advantages of the droplet digital PCR of infectious diseases such as bacterial, viral, and parasitic indications. Digital PCR provides more accurate, sensitive, and reproductive detection of pathogens according to the National Center for Biotechnology and it is better than real time polymerase chain reaction that are used for clinical diagnostics. The demand of oncology is increasing owing to the growing prevalence of the condition and introduction of new product launches. Oncology are estimated to register the highest CAGR over the period 2024–2030.
Digital PCR Market Segment Analysis — By Geography
North America dominated the Digital PCR Market with a major share of 37.6% in 2020. This is attributed to the high prevalence & diagnosis rates for infectious disease and high awareness among patient population towards new diagnostic options. Availability of digital PCR devices, rising incidences of various types of cancer and metabolic diseases requiring advanced diagnosis and therapeutics is also increasing the growth of the market in this region.
However, Asia Pacific is estimated to grow at a higher CAGR during the forecast period 2024–2030 owing to the growing patient awareness regarding advanced digital polymerase chain reaction devices. Developing Healthcare infrastructure is also increasing the growth of the market in this region.
Buy Now
Digital PCR Market Drivers
Technological Advancements in Digital PCR
Technological advancements in digital PCR is increasing the growth of the Digital PCR Market. This is attributed to the growing demand for innovative devices and increasing research & development activities. Digital PCR is used to quantify and amplify nuclei acid. The introduction of various technologically advanced devices such as droplet digital PCR, chip based, and beam digital PCR is offering great benefits to the market. Thus, increasing the growth of the Digital PCR Market during the forecast period 2024–2030.
Growing Adoption of Digital PCR over Realtime PCR
Growing adoption of digital PCR over Realtime PCR is increasing the growth of the Digital PCR Market. This is attributed to the fact that digital PCR helps to deliver a compete measure to target nucleic acid molecules that is achieved from real time PCR. DNA quantification allows for reproducibility, precision, and sensitive that enables the researches to quantify smaller differences and measure minor variants very precisely. Thus, increasing the growth of the Digital PCR Market during the forecast period 2024–2030.
Digital PCR Market Challenges
High Cost of Digital PCR Devices and Reimbursement Issues Along with the Technical Limitations of PCR
Some of the factors that are set to impede the growth of the Digital PCR Market are high cost of digital PCR devices and reimbursement issues along with the technical limitations of PCR. The adoption of digital polymerase chain reaction techniques is limited owing to the lack of awareness about the digital PCR and the use of its advanced types.
Digital PCR Market Landscape
Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Digital PCR Market. In 2020, the Digital PCR Market share is consolidated by the top ten players present in the market. Digital PCR Market, top 10 companies are Thermo Fisher Scientific Inc., BioMerieux SA, Stilla Technologies, Merck KgaA, Combinati Inc., and Bio-Rad Laboratories among others.
For more Lifesciences and Healthcare Market reports, please click here
0 notes
trendingreportz · 2 months ago
Text
Single-cell Genome Sequencing Market - Forecast(2024 - 2030)
Single-cell Genome Sequencing Market Overview 
The Single-cell Genome Sequencing size is estimated to reach $9 billion by 2030, growing at a CAGR of 16.2% during the forecast period 2023-2030. Single-cell genome sequencing is one of the major areas of research for finding a cure for chronic ailments such as cancer. The rising cases of cancer worldwide would drive the Single-cell Genome Sequencing Market during the forecast period. According to Cancer.org, the global burden of new cancer cases would grow to 27.5 million by 2040. This would certainly boost the demand for Single-cell Genome Sequencing Market to find a cure for such chronic diseases.
Rapid development in sequencing technologies is also expected to drive the growth of this market during the forecast period. Polymerase chain reaction (PCR) and next-generation sequencing are emerging as the preferred technologies for various applications, especially for single-cell genomic sequencing. In January 2022, a group of medical Scientists at Stanford and their collaborators developed a new ultra-fast genome sequencing approach that offered a diagnostic rate of about 12% higher than the average rate for diagnosing mystery illnesses.
Request Sample
Single-cell Genome Sequencing Market - Report Coverage:
The “Single-cell Genome Sequencing Market Report- Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Single-cell Genome Sequencing Market.AttributeSegment
By Product Type
Consumables
Reagents
By Technique
Flow Cytometry
Next-generation Sequencing
Polymerase Chain Reaction
Microscopy
Mass Spectrometry
Others
By Application
Cancer
Immunology
Microbiology
Others
By End-User
Academic and Research Laboratories
Hospitals and Diagnostic Centers
Biotechnology and Pharmaceutical Companies
Cell Banks and IVF Centers
By Geography
North America (the U.S., Canada and Mexico)
Europe (Germany, France, the UK, Italy, Spain, Russia and the Rest of Europe),
Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand and the Rest of Asia-Pacific),
South America (Brazil, Argentina, Chile, Colombia and the Rest of South America)
The Rest of the World (the Middle East and Africa).
COVID-19 / Ukraine Crisis - Impact Analysis: 
The COVID-19 pandemic had a positive impact on the Single-cell Genome Sequencing Market. The studies on single-cell genome sequencing offered critical insights into coronavirus infection and allowed medical experts better understand the nature of the infection. On performing single-cell sequencing, most cell types in patients with COVID-19 showed a significant interferon-α response along with an overall acute inflammatory response.
 Russia’s invasion of Ukraine has made a significant impact on the Single-cell Genome Sequencing market. It has not only affected the lives and work of genomic researchers in these countries but has also influenced the relationships with colleagues in the U.S. and elsewhere.
The sanctions against Russia are most likely to bring experimental genomics research in the country to a halt. Ukraine had several genomics research projects going on before the war began. Now, with all the unrest, most researchers in Ukraine are fleeing the country and looking for positions in the west.
Inquiry Before Buying
Key Takeaways: 
Fastest Growth in the Asia-Pacific Region : Geographically, in the global Single-cell Genome Sequencing market share, Asia-Pacific is analyzed to grow with the highest CAGR of 17.2% during the forecast period 2023-2030. This growth is driven by the rising number of cancer cases in the region. According to the projections by the International Agency for Research on Cancer, there would be about 15.1 million new cases per year in Asia until 2040. The unprecedented rate of population aging is the key determinant of this development. Japan, the country with the oldest population in the world, also has the highest rate of cancer. This would drive growth in the Single-cell Genome Sequencing Market in the region during the forecast period.
Reagents Segment to Register the Fastest Growth : In the Single-cell Genome Sequencing analysis, the Reagents segment is estimated to grow with the highest CAGR of 17% during the forecast period. This is because the use of single-cell sequencing reagents allows the experts to process bulk samples with the input of as few as 100 cells. With the recent advancements in single-cell DNA sequencing techniques, bulk DNA sequencing can be done more efficiently and cost-effectively. Moreover, commercial reagents are now available for all the wet-lab steps of a scRNA-seq protocol as well as for preparing barcoded cDNA libraries. The increasing availability of reagents and their growing need in various single-cell genome sequencing processes are boosting its growth in the Single-cell Genome Sequencing Market during the forecast period.
Academic and Research Laboratories Segment is Leading the Market : According to the Single-Cell Genome Sequencing Market forecast, the academic and research laboratories segment held the largest market share of 38.6% in 2022. Single-cell genomics is emerging as one of the major areas in scientific research and development. The rising prevalence of chronic diseases demands new cures and treatment options, which is further boosting the growth of the academic and research laboratories segment. Moreover, understanding the genomics of individual cells opens up a new set of opportunities for the world of biotechnology.
Increased Funding for Vaccine Development and Production : Government agencies in various parts of the world have increased funding for the development and production of vaccines in response to the pandemic. This has led to increased use of single-cell analysis (SCA) tools for COVID-19 research. SCA helps in the assessment of the peripheral immune function of the disease and contributes to the study of the pathophysiology and treatment possibilities of the disease. Thus, the market is positively impacted by COVID-19.
Massive Demand in the field of Immunology, Oncology and Others : Single-cell technology is used in the molecular-level examination of processes and pathways of cellular heterogeneity along with its assessment. This rapidly developing technology has major applications in immunology, oncology and other major areas. Moreover, the development of advanced tools that help make proteomic and transcriptomic processes simpler is also driving the use of single-cell analysis methods, boosting the growth of the Single-cell Genome Sequencing Market.
High Cost of Instruments to Hinder Market Growth : While there is a significant demand for genome sequencing machines among the end-user industries, the instrument costs are significantly high. According to a report published in Bloomberg, Illumina’s new NovaSeq X series costs $985,000 for the base machine and $1.25 million for the advanced one. Such high cost of instruments are likely to hinder the growth of the Single-cell Genome Sequencing Market.
Schedule a Call
Key Market Players:
Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Single-Cell Genome Sequencing Market.
The top 10 companies in this industry are listed below:
Standard BioTools Inc. (Maxpar®, Advanta™ Assays)
QIAGEN N.V. (QIAseq FX, REPLI-g)
Illumina, Inc. (NovaSeq, NextSeq)
F. Hoffmann-La Roche AG (AVENIO, MagNA Pure)
Thermo Fisher Scientific, Inc. (Invitrogen, Applied Biosystems)
Bio-Rad Laboratories, Inc. (SEQuoia, ddSEQ)
10X Genomics, Inc. (Chromium, Visium)
Becton, Dickinson and Company (BD Rhapsody™, BD AbSeq)
Oxford Nanopore Technologies Limited (MinION, GridION)
Beijing Genomics Institute Group (CardioGen, COLOTECT™)
 Buy Now
Scope of the Report:
Report MetricDetails
Base Year Considered
2022
Forecast Period
2023–2030
CAGR
16.2%
Market Size in 2030
$9 billion
Segments Covered
Product Type, Technique, Application, End-user and Region
Geographies Covered
North America (the U.S., Canada and Mexico) Europe (Germany, France, the UK, Italy, Spain, Russia and the Rest of Europe),Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand and the Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America) and the Rest of the World (the Middle East and Africa).
Key Market Players
Standard BioTools Inc.
QIAGEN N.V.
Illumina, Inc.
F. Hoffmann-La Roche AG
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
10X Genomics, Inc.
Becton, Dickinson and Company
Oxford Nanopore Technologies Limited
Beijing Genomics Institute Group
Pacific Biosciences of California, Inc.
NuGEN Technologies, Inc.
Novogene Co. Ltd.
Takara Bio, Inc.
Danaher Corporation
0 notes